A Letter to our Community: Women’s Health in Today’s America

In our first blog of the Top 10 Deals of 2024 series, we showcase the acquisition of The HoneyPot Company by Compass Diversified.

Amboy Street Ventures is thrilled to announce its investment in Testmate, an at-home diagnostic test for STIs (gonorrhea, chlamydia) with immediate results.

Amboy Street Ventures is excited to announce its latest investment in Playground, Christina Aguilera’s sexual wellness company.

As the ARPA-H Sprint for Women’s Health grant proposals are due on Monday, April 15th, this week NIH Scientific Reviewer, Carolyn Kreuzkamp, gives advice on how to have a successful proposal.

If you are keeping up with Women’s Health news, you saw Biden’s recent commitment to improve funding, research and education in the sector. But what does it mean for Women’s Health startups and how can they access the allocated resources?

To conclude our “Top 10 Deals of 2023” blog series, we answer the question - “WHY DOES IT MATTER?”.

For our final deal of our Top 10 Deals of 2023 series, we look at a notable women's health acquisition in generic medicines. This deal proves pharmaceutical players’ appetite for women’s health products and bodes well for future innovation in the field.

This week we review the reproductive health and obstetrics landscape following CooperCompanies’ acquisition of Cook Medical’s OBGYN product line.

This week we explore the acquisition of Bonafide Health, a significant deal in the Menopause space. This strategic move marks a pivotal shift, bringing much-needed attention to an often overlooked area of women’s health.